Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nathan Subramaniam

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Gastroenterology|September 4, 2016
Genetic Variants in the BMP6 Pro-Peptide May Not Cause Iron Loading and Should Be Interpreted With CautionCameron J McDonald, Gautam Rishi, Daniel F Wallace, et al.
Journal of Hepatology|July 19, 2005
Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytesDaniel F Wallace, Lesa Summerville, Patricia E Lusby, et al.
Plos One|October 25, 2013
In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interactGautam Rishi, Emily M Crampton, Daniel F Wallace, et al.
Pharmaceuticals (Basel, Switzerland)|November 29, 2019
Therapeutic Advances in Regulating the Hepcidin/Ferroportin AxisZachary J Hawula, Daniel F Wallace, V Nathan Subramaniam, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 27, 2015
Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2Gautam Rishi, Eriza S Secondes, Daniel F Wallace, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 29, 2013
Parenteral vs. oral iron: influence on hepcidin signaling pathways through analysis of Hfe/Tfr2-null miceCameron J McDonald, Daniel F Wallace, Lesa Ostini, et al.
Scientific Reports|September 12, 2015
Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidinJustin B Goh, Daniel F Wallace, Wanjin Hong, et al.
American Journal of Hematology|May 13, 2016
Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemiaGautam Rishi, Eriza S Secondes, Daniel F Wallace, et al.
American Journal of Physiology. Cell Physiology|December 21, 2007
Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosisDaniel F Wallace, Lesa Summerville, Emily M Crampton, et al.
Clinical Chemistry|August 17, 2021
Genetic Diagnosis in Hereditary Hemochromatosis: Discovering and Understanding the Biological Relevance of VariantsFloor S Baas, Gautam Rishi, Dorine W Swinkels, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Gastroenterology|September 4, 2016
Genetic Variants in the BMP6 Pro-Peptide May Not Cause Iron Loading and Should Be Interpreted With CautionCameron J McDonald, Gautam Rishi, Daniel F Wallace, et al.
Journal of Hepatology|July 19, 2005
Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytesDaniel F Wallace, Lesa Summerville, Patricia E Lusby, et al.
Plos One|October 25, 2013
In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interactGautam Rishi, Emily M Crampton, Daniel F Wallace, et al.
Pharmaceuticals (Basel, Switzerland)|November 29, 2019
Therapeutic Advances in Regulating the Hepcidin/Ferroportin AxisZachary J Hawula, Daniel F Wallace, V Nathan Subramaniam, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 27, 2015
Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2Gautam Rishi, Eriza S Secondes, Daniel F Wallace, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 29, 2013
Parenteral vs. oral iron: influence on hepcidin signaling pathways through analysis of Hfe/Tfr2-null miceCameron J McDonald, Daniel F Wallace, Lesa Ostini, et al.
Scientific Reports|September 12, 2015
Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidinJustin B Goh, Daniel F Wallace, Wanjin Hong, et al.
American Journal of Hematology|May 13, 2016
Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemiaGautam Rishi, Eriza S Secondes, Daniel F Wallace, et al.
American Journal of Physiology. Cell Physiology|December 21, 2007
Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosisDaniel F Wallace, Lesa Summerville, Emily M Crampton, et al.
Clinical Chemistry|August 17, 2021
Genetic Diagnosis in Hereditary Hemochromatosis: Discovering and Understanding the Biological Relevance of VariantsFloor S Baas, Gautam Rishi, Dorine W Swinkels, et al.
Pageof 11